These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 14999460)

  • 21. Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients.
    Lavoie S; Murray MM; Deppen P; Knyazeva MG; Berk M; Boulat O; Bovet P; Bush AI; Conus P; Copolov D; Fornari E; Meuli R; Solida A; Vianin P; Cuénod M; Buclin T; Do KQ
    Neuropsychopharmacology; 2008 Aug; 33(9):2187-99. PubMed ID: 18004285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What has MMN revealed about the auditory system in schizophrenia?
    Michie PT
    Int J Psychophysiol; 2001 Oct; 42(2):177-94. PubMed ID: 11587775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia.
    Javitt DC; Doneshka P; Grochowski S; Ritter W
    Arch Gen Psychiatry; 1995 Jul; 52(7):550-8. PubMed ID: 7598631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mismatch negativity (MMN) and sensory auditory processing in children aged 9-12 years presenting with putative antecedents of schizophrenia.
    Bruggemann JM; Stockill HV; Lenroot RK; Laurens KR
    Int J Psychophysiol; 2013 Sep; 89(3):374-80. PubMed ID: 23707338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain potential evidence for an auditory sensory memory deficit in schizophrenia.
    Catts SV; Shelley AM; Ward PB; Liebert B; McConaghy N; Andrews S; Michie PT
    Am J Psychiatry; 1995 Feb; 152(2):213-9. PubMed ID: 7840354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Auditory change detection in schizophrenia: sources of activity, related neuropsychological function and symptoms in patients with a first episode in adolescence, and patients 14 years after an adolescent illness-onset.
    Oades RD; Wild-Wall N; Juran SA; Sachsse J; Oknina LB; Röpcke B
    BMC Psychiatry; 2006 Feb; 6():7. PubMed ID: 16466573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mismatch Negativity is a Sensitive and Predictive Biomarker of Perceptual Learning During Auditory Cognitive Training in Schizophrenia.
    Perez VB; Tarasenko M; Miyakoshi M; Pianka ST; Makeig SD; Braff DL; Swerdlow NR; Light GA
    Neuropsychopharmacology; 2017 Oct; 42(11):2206-2213. PubMed ID: 28139679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed peak latency of the mismatch negativity in schizophrenics and alcoholics.
    Kathmann N; Wagner M; Rendtorff N; Engel RR
    Biol Psychiatry; 1995 May; 37(10):754-7. PubMed ID: 7640331
    [No Abstract]   [Full Text] [Related]  

  • 29. Electrophysiological evidence of corollary discharge dysfunction in schizophrenia during talking and thinking.
    Ford JM; Mathalon DH
    J Psychiatr Res; 2004 Jan; 38(1):37-46. PubMed ID: 14690769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deviant matters: duration, frequency, and intensity deviants reveal different patterns of mismatch negativity reduction in early and late schizophrenia.
    Todd J; Michie PT; Schall U; Karayanidis F; Yabe H; Näätänen R
    Biol Psychiatry; 2008 Jan; 63(1):58-64. PubMed ID: 17585889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired cortical network for preattentive detection of change in speech sounds in schizophrenia: a high-resolution event-related potential study.
    Kasai K; Nakagome K; Itoh K; Koshida I; Hata A; Iwanami A; Fukuda M; Kato N
    Am J Psychiatry; 2002 Apr; 159(4):546-53. PubMed ID: 11925291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gray matter deficits, mismatch negativity, and outcomes in schizophrenia.
    Rasser PE; Schall U; Todd J; Michie PT; Ward PB; Johnston P; Helmbold K; Case V; Søyland A; Tooney PA; Thompson PM
    Schizophr Bull; 2011 Jan; 37(1):131-40. PubMed ID: 19561058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mismatch negativity indexes illness-specific impairments of cortical plasticity in schizophrenia: a comparison with bipolar disorder and Alzheimer's disease.
    Baldeweg T; Hirsch SR
    Int J Psychophysiol; 2015 Feb; 95(2):145-55. PubMed ID: 24681247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duration mismatch negativity in biological relatives of patients with schizophrenia spectrum disorders.
    Michie PT; Innes-Brown H; Todd J; Jablensky AV
    Biol Psychiatry; 2002 Oct; 52(7):749-58. PubMed ID: 12372666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia.
    Javitt DC; Lee M; Kantrowitz JT; Martinez A
    Schizophr Res; 2018 Jan; 191():51-60. PubMed ID: 28666633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A predictive coding account of MMN reduction in schizophrenia.
    Wacongne C
    Biol Psychol; 2016 Apr; 116():68-74. PubMed ID: 26582536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Event-related potential correlates of impaired selective attention in children at high risk for schizophrenia.
    Schreiber H; Stolz-Born G; Kornhuber HH; Born J
    Biol Psychiatry; 1992 Oct; 32(8):634-51. PubMed ID: 1457620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral and electrophysiological indices of temporal processing dysfunction in schizophrenia.
    Davalos DB; Kisley MA; Freedman R
    J Neuropsychiatry Clin Neurosci; 2005; 17(4):517-25. PubMed ID: 16387992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mismatch negativity and N2b attenuation as an indicator for dysfunction of the preattentive and controlled processing for deviance detection in schizophrenia: a topographic event-related potential study.
    Kasai K; Okazawa K; Nakagome K; Hiramatsu K; Hata A; Fukuda M; Honda M; Miyauchi M; Matsushita M
    Schizophr Res; 1999 Jan; 35(2):141-56. PubMed ID: 9988851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Auditory mismatch negativity and P3a in response to duration and frequency changes in the early stages of psychosis.
    Nagai T; Tada M; Kirihara K; Yahata N; Hashimoto R; Araki T; Kasai K
    Schizophr Res; 2013 Nov; 150(2-3):547-54. PubMed ID: 24012461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.